| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |